191 related articles for article (PubMed ID: 2943050)
1. Effect of four weeks' high dose ipratropium bromide treatment on lung mucociliary clearance.
Taylor RG; Pavia D; Agnew JE; Lopez-Vidriero MT; Newman SP; Lennard-Jones T; Clarke SW
Thorax; 1986 Apr; 41(4):295-300. PubMed ID: 2943050
[TBL] [Abstract][Full Text] [Related]
2. Effect of ipratropium bromide on mucociliary clearance and pulmonary function in reversible airways obstruction.
Pavia D; Bateman JR; Sheahan NF; Clarke SW
Thorax; 1979 Aug; 34(4):501-7. PubMed ID: 159510
[TBL] [Abstract][Full Text] [Related]
3. Clearance of lung secretions in patients with chronic bronchitis: effect of terbutaline and ipratropium bromide aerosols.
Pavia D; Bateman JR; Sheahan NF; Clarke SW
Eur J Respir Dis; 1980 Oct; 61(5):245-53. PubMed ID: 6451446
[TBL] [Abstract][Full Text] [Related]
4. Comparative dose-response study of three anticholinergic agents and fenoterol using a metered dose inhaler in patients with chronic obstructive pulmonary disease.
Ikeda A; Nishimura K; Koyama H; Izumi T
Thorax; 1995 Jan; 50(1):62-6. PubMed ID: 7886652
[TBL] [Abstract][Full Text] [Related]
5. Sputum changes associated with the use of ipratropium bromide.
Ghafouri MA; Patil KD; Kass I
Chest; 1984 Sep; 86(3):387-93. PubMed ID: 6236043
[TBL] [Abstract][Full Text] [Related]
6. Use of ipratropium bromide in patients with severe airways obstruction.
Pierce RJ; Holmes PW; Campbell AH
Aust N Z J Med; 1982 Feb; 12(1):38-43. PubMed ID: 6211167
[TBL] [Abstract][Full Text] [Related]
7. Dose response study of ipratropium bromide aerosol on maximum exercise performance in stable patients with chronic obstructive pulmonary disease.
Ikeda A; Nishimura K; Koyama H; Tsukino M; Mishima M; Izumi T
Thorax; 1996 Jan; 51(1):48-53. PubMed ID: 8658369
[TBL] [Abstract][Full Text] [Related]
8. Regional lung clearance during cough and forced expiration technique (FET): effects of flow and viscoelasticity.
Hasani A; Pavia D; Agnew JE; Clarke SW
Thorax; 1994 Jun; 49(6):557-61. PubMed ID: 8016793
[TBL] [Abstract][Full Text] [Related]
9. Double-blind study of ipratropium bromide, a new anticholinergic bronchodilator.
Chervinsky P
J Allergy Clin Immunol; 1977 Jan; 59(1):22-30. PubMed ID: 137921
[TBL] [Abstract][Full Text] [Related]
10. Failure of ipratropium bromide to modify the diurnal variation of asthma in asthmatic children.
Sly PD; Landau LI; Olinsky A
Thorax; 1987 May; 42(5):357-60. PubMed ID: 2958950
[TBL] [Abstract][Full Text] [Related]
11. Severe exacerbations of COPD and asthma. Incremental benefit of adding ipratropium to usual therapy.
Patrick DM; Dales RE; Stark RM; Laliberte G; Dickinson G
Chest; 1990 Aug; 98(2):295-7. PubMed ID: 2142915
[TBL] [Abstract][Full Text] [Related]
12. Dose-response comparison of ipratropium bromide from a metered-dose inhaler and by jet nebulisation.
Gomm SA; Keaney NP; Hunt LP; Allen SC; Stretton TB
Thorax; 1983 Apr; 38(4):297-301. PubMed ID: 6223402
[TBL] [Abstract][Full Text] [Related]
13. A comparison of oxitropium bromide and ipratropium bromide in asthma.
Peel ET; Anderson G; Cheong B; Broderick N
Eur J Respir Dis; 1984 Feb; 65(2):106-8. PubMed ID: 6230249
[TBL] [Abstract][Full Text] [Related]
14. Nebulised ipratropium bromide and sodium cromoglycate in the first two years of life.
Henry RL; Hiller EJ; Milner AD; Hodges IG; Stokes GM
Arch Dis Child; 1984 Jan; 59(1):54-7. PubMed ID: 6230059
[TBL] [Abstract][Full Text] [Related]
15. Influence of 0.2 mg ipratropium bromide on mucociliary clearance in patients with chronic bronchitis.
Matthys H; Hundenborn J; Daikeler G; Köhler D
Respiration; 1985; 48(4):329-39. PubMed ID: 2934779
[TBL] [Abstract][Full Text] [Related]
16. A therapeutic comparison of ipratropium bromide and salbutamol in asthmatic patients.
Bell R; Sahay JN; Barber PV; Chatterjee SS; Cox G
Curr Med Res Opin; 1982; 8(4):242-6. PubMed ID: 6217949
[TBL] [Abstract][Full Text] [Related]
17. Effects of theophylline and ipratropium bromide on exercise performance in patients with stable chronic obstructive pulmonary disease.
Tsukino M; Nishimura K; Ikeda A; Hajiro T; Koyama H; Izumi T
Thorax; 1998 Apr; 53(4):269-73. PubMed ID: 9741369
[TBL] [Abstract][Full Text] [Related]
18. Effects of corticosteroids on bronchodilator action in chronic obstructive lung disease.
Wempe JB; Postma DS; Breederveld N; Kort E; van der Mark TW; Koëter GH
Thorax; 1992 Aug; 47(8):616-21. PubMed ID: 1412119
[TBL] [Abstract][Full Text] [Related]
19. Ipratropium bromide in asthma. A review of the literature.
Schlueter DP
Am J Med; 1986 Nov; 81(5A):55-60. PubMed ID: 2947461
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic equivalence of a novel HFA134a-containing metered-dose inhaler and the conventional CFC inhaler (Berodual) for the delivery of a fixed combination of fenoterol/ipratropium bromide. A randomized double-blind placebo-controlled crossover study in patients with asthma.
Maesen FP; Greefhorst LP; Smeets JJ; Wald FD; Cornelissen PJ
Respiration; 1997; 64(4):273-80. PubMed ID: 9257362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
